Abstract
Current efforts toward developing treatments to delay the symptoms of AD will not be adequate to overcome the demographic forces which are increasing the total number of affected individuals. The prevalence of AD increases nearly exponentially with age, that is, the percentage of the population affected doubles every decade beyond age 65. By delaying the onset of disabling symptoms for all age groups by five to ten years, it would be possible to reduce the number of people affected by half and cut the cost of care significantly.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Birkhäuser Boston
About this chapter
Cite this chapter
Khachaturian, Z.S., Radebaugh, T.S. (1997). The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association. In: Becker, R.E., Giacobini, E., Barton, J.M., Brown, M. (eds) Alzheimer Disease. Advances in Alzheimer Disease Therapy. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4116-4_91
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4116-4_91
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4612-8660-8
Online ISBN: 978-1-4612-4116-4
eBook Packages: Springer Book Archive